Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Inoue, Kana ^a   Kishida, Ken ^a,b   Hirata, Ayumu ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kishida Clinic   (Japan)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosapentaenoic acid; Metabolic syndrome; Obesity; Visceral fat

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; WAIST CIRCUMFERENCE;

EID: 84874790018     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-25     Document Type: Article

References (20)

1. Visceral adiposity as a target for the management of the metabolic syndrome. Kishida K, Funahashi T, Matsuzawa Y, Shimomura I, Ann Med 2012 44 233 241 10.3109/07853890.2011.564202 21612331
2. Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases. Siegel G, Ermilov E, Atherosclerosis 2012 225 291 295 10.1016/j.atherosclerosis. 2012.09.006 23031363
3. Consequences of essential Fatty acids. Lands B, Nutrients 2012 4 1338 1357 10.3390/nu4091338 23112921
4. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, Shirai S, Kondo K, Sakai K, Goya M, Iwabuchi M, Ueeda M, Nobuyoshi M, Circ J 2012 76 423 429 10.1253/circj.CJ-11-0941 22156311
5. Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio. Kashiyama T, Ueda Y, Nemoto T, Wada M, Masumura Y, Matsuo K, Nishio M, Hirata A, Asai M, Kashiwase K, Kodama K, Circ J 2011 75 2432 2438 10.1253/circj.CJ-11-0352 21778590
6. Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction. Ueeda M, Doumei T, Takaya Y, Ohnishi N, Takaishi A, Hirohata S, Miyoshi T, Shinohata R, Usui S, Kusachi S, Hear Vessel 2011 26 145 152 10.1007/s00380-010-0038-8
7. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, Yamaguchi T, Funahashi T, Matsuzawa Y, Nakamura T, Shimomura I, Diabetes Care 2005 28 451 453 10.2337/diacare.28.2.451 15677816 (Pubitemid 40170963)
8. Revised equations for estimated GFR from serum creatinine in Japan. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR, Am J Kidney Dis 2009 53 982 992 10.1053/j.ajkd.2008.12.034 19339088
9. Metabolic syndrome. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M, J Atheroscler Thromb 2008 15 1 5 10.5551/jat.E580 18319538
10. New criteria for 'obesity disease' in Japan. Examination Committee of Criteria for 'Obesity Disease' in Japan, Circ J 2002 66 987 992 10.1253/circj.66.987 12419927 (Pubitemid 35416333)
11. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. de Lorgeril M, Salen P, BMC Med 2012 10 50 10.1186/1741-7015-10-50 22613931
12. Omega-3 fatty acids. Covington MB, Am Fam Physician 2004 70 133 140 15259529 (Pubitemid 38890768)
13. Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Minami A, Ishimura N, Sakamoto S, Takishita E, Mawatari K, Okada K, Nakaya Y, Br J Nutr 2002 87 157 162 10.1079/BJN2001496 11895168 (Pubitemid 34575539)
14. Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R, Ohmura H, Kiyanagi T, Hiki M, Fukao K, Sumiyoshi K, Hirose K, Matsumori R, Takizawa H, Fujii K, Mokuno H, Inoue N, Daida H, J Atheroscler Thromb 2010 17 285 294 10.5551/jat.2618 20228612
15. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nigam A, Frasure-Smith N, Lespérance F, Julien P, Nutr Metab Cardiovasc Dis 2009 19 264 270 10.1016/j.numecd.2008.07.008 18804984
16. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Simopoulos AP, Exp Biol Med (Maywood) 2008 233 674 688 10.3181/0711-MR-311
17. Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I, Am J Cardiol 2013 111 6 11 10.1016/j.amjcard.2012.08.038 23040588
18. Comparison of eicosapentaenoic acid concentrations in plasma between patients with ischemic stroke and control subjects. Ikeya Y, Fukuyama N, Kitajima W, Ogushi Y, Mori H, Nutrition 2013 29 127 131 10.1016/j.nut.2012.05. 003 23010418
19. Omega-3 fatty acids from fish oils and cardiovascular disease. Holub DJ, Holub BJ, Mol Cell Biochem 2004 263 217 225 15524182 (Pubitemid 39256160)
20. The utility of omega-3 fatty acids in cardiovascular disease. Saremi A, Arora R, Am J Ther 2009 16 421 436 10.1097/MJT.0b013e3180a5f0bb 19092647